
### [NCIT:C136610](http://purl.obolibrary.org/obo/NCIT_C136610)
**Label:** Bone Cancer by AJCC v7 Stage

**Subclasses:** [NCIT:C6705](http://purl.obolibrary.org/obo/NCIT_C6705) (Stage II Bone Sarcoma  AJCC v7), [NCIT:C6704](http://purl.obolibrary.org/obo/NCIT_C6704) (Stage I Bone Sarcoma  AJCC v7), [NCIT:C6468](http://purl.obolibrary.org/obo/NCIT_C6468) (Stage III Bone Sarcoma  AJCC v7), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C136632](http://purl.obolibrary.org/obo/NCIT_C136632) (Bone Sarcoma by AJCC v7 Stage), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C87178](http://purl.obolibrary.org/obo/NCIT_C87178) (Stage I Bone Cancer  AJCC v7), [NCIT:C87181](http://purl.obolibrary.org/obo/NCIT_C87181) (Stage II Bone Cancer  AJCC v7), [NCIT:C87185](http://purl.obolibrary.org/obo/NCIT_C87185) (Stage IV Bone Cancer  AJCC v7), [NCIT:C6706](http://purl.obolibrary.org/obo/NCIT_C6706) (Stage IV Bone Sarcoma  AJCC v7), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), [NCIT:C87184](http://purl.obolibrary.org/obo/NCIT_C87184) (Stage III Bone Cancer  AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 58.33%
- Thing 51.96%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 43.69%


